1. Academic Validation
  2. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

  • Oncogene. 1999 Nov 4;18(46):6183-90. doi: 10.1038/sj.onc.1203043.
J H Lee 1 T Takahashi N Yasuhara J Inazawa S Kamada Y Tsujimoto
Affiliations

Affiliation

  • 1 Department of Medical Genetics, Osaka University Graduate School of Medicine, Japan.
Abstract

Bcl-2 is the best characterized inhibitor of Apoptosis, although the molecular basis of this action is not fully understood. Using a protein interaction cloning procedure, we identified a human gene designated as bis (mapped to chromosome 10q25) that encoded a novel Bcl-2-interacting protein. Bis protein showed no significant homology with Bcl-2 Family proteins and had no prominent functional motif. Co-immunoprecipitation analysis confirmed that Bis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Bis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing Bax-induced and Fas-mediated Apoptosis. These results suggest that Bis is a novel modulator of cellular anti-apoptotic activity that functions through its interaction with Bcl-2.

Figures